Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2020 report provides comprehensive access to available records for over 1,100 asset purchase deals, including contract documents where available.
The report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets.
The focus of the report is on partnerships for business, product, technology and royalty assets where partners have entered an agreement to dispose of or acquire said assets.
Companies may seek to dispose of an asset simply because it is surplus to requirements. Or it may seek to dispose of assets in order to raise funds to invest in others parts of its business. Or it may be due to a regulatory requirement to dispose of certain business or product assets as a result of a pending business merger in order to meet competition regulations.